Study Suggests Side-Effects and Costs Are Biggest Issues for Users Of HIV Pre-Exposure Prophylaxis | Johns Hopkins Bloomberg School of Public Health
Survey of people who had previously used PrEP as well as those who had not found preference for long-acting injectable PrEP, which came to market earlier this year, over short-acting pills